The effect of tranexamic acid (TXA) on platelet function was examined in 37 patients with ruptured intracranial aneurysms. TXA was administered in a double-blind, placebo controlled manner to 37 patients with ruptured intracranial aneurysms. TXA was given to 17 patients in a dose of 9 g/24 hours, to another 6 patients in a dose of 6 g/24 hours; 14 patients were given a placebo. The effect of TXA on certain haemostatic function tests was evaluated between the treatment groups. We conclude that patients receiving TXA do not appear to be at risk of recurrent haemorrhage due to abnormal haemostasis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/s-2008-1052074 | DOI Listing |
Publication Analysis
Top Keywords
tranexamic acid
8
patients ruptured
8
ruptured intracranial
8
intracranial aneurysms
8
aneurysms txa
8
patients dose
8
dose g/24
8
g/24 hours
8
hours patients
8
patients
6
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!